Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Ventyx Biosciences Inc shares valued at $8,921 were sold by Krueger Christopher W on Apr 02 ’24. At $5.40 per share, Krueger Christopher W sold 1,651 shares. The insider’s holdings dropped to 284,999 shares worth approximately $0.63 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Nuss John sold 1,651 shares, netting a total of over 8,921 in proceeds. Following the sale of shares at $5.40 each, the insider now holds 264,998 shares.
Before that, Mohan Raju had sold 4,312 shares from its account. In a trade valued at $23,299, the CEO AND PRESIDENT traded Ventyx Biosciences Inc shares for $5.40 each. Upon closing the transaction, the insider’s holdings decreased to 4,312 shares, worth approximately $3.47 million.
As published in a research note from Wells Fargo on March 12, 2024, Ventyx Biosciences Inc [VTYX] has been rated up from an Equal weight to an Overweight and the price target has been revised to $16 from $7. Analysts at Oppenheimer upgraded the stock from ‘”a Perform”‘ to ‘”an Outperform”‘ outlook in a report released in mid March. As of November 07, 2023, Wells Fargo has decreased its “an Overweight” rating to a “an Equal weight” for VTYX. Earlier on November 07, 2023, Stifel downgraded its rating. Their new recommendation was “a Hold” for VTYX stock which previously was a “a Buy”.
Analyzing VTYX Stock Performance
During the last five days, there has been a surge of approximately 11.68%. Over the course of the year, Ventyx Biosciences Inc shares have dropped approximately -10.93%. Shares of the company reached a 52-week high of $11.48 on 03/08/24 and a 52-week low of $1.79 on 08/22/24. A 50-day SMA is recorded $2.33, while a 200-day SMA reached $3.58. Nevertheless, trading volume fell to 0.51 million shares from 0.87 million shares the previous day.
Support And Resistance Levels for Ventyx Biosciences Inc (VTYX)
According to the 24-hour chart, there is a support level at 2.14, which, if violated, would cause prices to drop to 2.07. In the upper region, resistance lies at 2.29. The next price resistance is at 2.37. RSI (Relative Strength Index) is 49.19 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.15, which suggests the price will decrease in the coming days. Percent R is at 34.40%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
